Compare CHOW & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHOW | TXMD |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.5M | 25.9M |
| IPO Year | 2025 | N/A |
| Metric | CHOW | TXMD |
|---|---|---|
| Price | $0.64 | $2.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 17.5M | 98.0K |
| Earning Date | 01-01-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.82 | N/A |
| EPS | ★ 0.07 | 0.03 |
| Revenue | ★ $33,343,904.00 | $2,796,000.00 |
| Revenue This Year | N/A | $427.09 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $9.11 | $90.45 |
| Revenue Growth | 73.74 | ★ 75.19 |
| 52 Week Low | $0.39 | $0.72 |
| 52 Week High | $21.91 | $2.95 |
| Indicator | CHOW | TXMD |
|---|---|---|
| Relative Strength Index (RSI) | 39.64 | 54.38 |
| Support Level | $0.39 | $2.12 |
| Resistance Level | $1.38 | $2.54 |
| Average True Range (ATR) | 0.12 | 0.24 |
| MACD | 0.14 | -0.02 |
| Stochastic Oscillator | 23.42 | 32.18 |
ChowChow Cloud International Holdings Ltd is providing one-stop cloud solutions that support companies across the IT industry value chain throughout their entire cloud transformation journey from consulting, deployment and migration to cloud environment building and management. Its business comprises (i) digital transformation consulting services consisting of cloud suitability assessment (ii) professional IT services comprising of capabilities designed to facilitate seamless cloud integration and digital transformation, (iii) AI-powered proactive cloud managed services covering all aspects of day-to-day cloud maintenance and support, and (iv) IT infrastructure solutions covering on-premise private cloud setups and public cloud integrations including infrastructure applications.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.